BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12165861)

  • 1. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators.
    Conte N; Charafe-Jauffret E; Delaval B; Adélaïde J; Ginestier C; Geneix J; Isnardon D; Jacquemier J; Birnbaum D
    Oncogene; 2002 Aug; 21(36):5619-30. PubMed ID: 12165861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TACC1-chTOG-Aurora A protein complex in breast cancer.
    Conte N; Delaval B; Ginestier C; Ferrand A; Isnardon D; Larroque C; Prigent C; Séraphin B; Jacquemier J; Birnbaum D
    Oncogene; 2003 Nov; 22(50):8102-16. PubMed ID: 14603251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system.
    Wilson SH; Bailey AM; Nourse CR; Mattei MG; Byrne JA
    Genomics; 2001 Aug; 76(1-3):81-8. PubMed ID: 11549320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon.
    Still IH; Hamilton M; Vince P; Wolfman A; Cowell JK
    Oncogene; 1999 Jul; 18(27):4032-8. PubMed ID: 10435627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines.
    Xiang J; Qiu W; Wang X; Zhou F; Wang Z; Liu S; Yue L
    Oncol Rep; 2013 Apr; 29(4):1517-23. PubMed ID: 23354013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation.
    Oien KA; McGregor F; Butler S; Ferrier RK; Downie I; Bryce S; Burns S; Keith WN
    J Pathol; 2004 Jul; 203(3):789-97. PubMed ID: 15221938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of breast cancer cell lines by a low-density microarray.
    de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
    Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and spatial expression of TACC1 in the mouse and human.
    Lauffart B; Dimatteo A; Vaughan MM; Cincotta MA; Black JD; Still IH
    Dev Dyn; 2006 Jun; 235(6):1638-47. PubMed ID: 16496324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
    Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
    Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
    Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
    Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines.
    Still IH; Vince P; Cowell JK
    Genomics; 1999 Jun; 58(2):165-70. PubMed ID: 10366448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human SOX18 in normal tissues and tumors.
    Saitoh T; Katoh M
    Int J Mol Med; 2002 Sep; 10(3):339-44. PubMed ID: 12165811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells.
    Charafe-Jauffret E; Moulin JF; Ginestier C; Bechlian D; Conte N; Geneix J; Adélaïde J; Noguchi T; Hassoun J; Jacquemier J; Birnbaum D
    Int J Oncol; 2002 Nov; 21(5):989-96. PubMed ID: 12370745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases.
    Gangisetty O; Lauffart B; Sondarva GV; Chelsea DM; Still IH
    Oncogene; 2004 Apr; 23(14):2559-63. PubMed ID: 14767476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.
    Ghayad SE; Vendrell JA; Bieche I; Spyratos F; Dumontet C; Treilleux I; Lidereau R; Cohen PA
    J Mol Endocrinol; 2009 Feb; 42(2):87-103. PubMed ID: 18984771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.